Abstract
Abstract The consortium RESPONSE is a cooperation between partners from science and industry within the BMBF-Program “Twenty20 - Partnership for Innovation”, 2014-2021. RESPONSE gives its partners opportunities to put medical device innovations into practice more efficiently. In order to accelerate innovation processes, joint efforts are being made along the entire translation chain. RESPONSE is focusing on the development of novel concepts of implantable medical devices for cardiovascular, ophthalmologic and ENT application. Platform technology approaches are being used to extend the range of device applications. See also: www.response.uni-rostock.de
Highlights
The consortium RESPONSE is a cooperation between partners from science and industry within the BMBF-Program “Twenty20 – Partnership for Innovation”, 2014-2021
RESPONSE is active in the field of engineering and testing of stent-based combination products, such as absorbable intravascular magnesium scaffolds for cardiovascular application [1]
Novel fabrication technologies are being adapted for the application in implant technology, such as laser machining, additive manufacturing or electrospinning of polymeric nonwoven fabrics
Summary
The consortium RESPONSE is a cooperation between partners from science and industry within the BMBF-Program “Twenty20 – Partnership for Innovation”, 2014-2021. The coordinated research project “RESPONSE – Partnership for Innovation in Implant Technology” (BMBF program Twenty20 – Partnership for Innovation, 2014 - 2021) is focusing on the development of novel concepts of implantable medical devices for cardiovascular, ophthalmologic and otorhinolaryngologic application. Major platform technologies of the RESPONSE consortium comprise stent technology, as well as medical device/drug
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
